Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.799
+0.008 (1.07%)
Nov 21, 2024, 1:42 PM EST - Market open

Omega Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-73.09-97.43-102.7-68.28-29.45-17.95
Depreciation & Amortization
7.316.775.191.391.150.79
Other Amortization
0.060.050.070.090.050.04
Loss (Gain) From Sale of Assets
0-0.23--00.03-
Loss (Gain) From Sale of Investments
0.02-0.191.050.03--
Stock-Based Compensation
8.488.797.753.180.640.34
Other Operating Activities
-0.090.011.32-0.11-0.08
Change in Accounts Receivable
-0.09-5.51-0.36-0.26--
Change in Accounts Payable
-0.97-1.490.991.040.140.67
Change in Other Net Operating Assets
2.71-2.37-10.513.881.430.51
Operating Cash Flow
-55.58-91.51-98.52-57.61-26.13-15.68
Capital Expenditures
-2.06-2.87-1.38-1.47-1.81-0.89
Sale of Property, Plant & Equipment
0.650.65----
Investment in Securities
7.649.73-16.68-38.93--
Investing Cash Flow
6.1947.52-18.06-40.4-1.81-0.89
Long-Term Debt Issued
-2.62-8-4
Long-Term Debt Repaid
--1----
Net Debt Issued (Repaid)
-2.031.62-8-4
Issuance of Common Stock
0.0340.490.71131.510.10.02
Other Financing Activities
--0.29--3.47-0.08-0.04
Financing Cash Flow
-241.820.71261.5448.6211.99
Net Cash Flow
-51.39-2.17-115.87163.5320.68-4.58
Free Cash Flow
-57.64-94.38-99.9-59.08-27.94-16.56
Free Cash Flow Margin
-712.04%-3050.39%-4818.86%-41025.00%--
Free Cash Flow Per Share
-1.04-1.75-2.09-2.64-7.15-4.99
Cash Interest Paid
0.441.721.260.750.730.56
Levered Free Cash Flow
-38-60.18-57.24-34.32-16.57-
Unlevered Free Cash Flow
-36.93-59.11-56.49-33.79-16.13-
Change in Net Working Capital
-2.069.143.83-4.38-1.8-
Source: S&P Capital IQ. Standard template. Financial Sources.